Screener
Cytek Biosciences, Inc. CTKB Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s shares (diluted)?
- Cytek Biosciences, Inc. (CTKB) reported shares (diluted) of 129.5M in Q2 2026.
- How has Cytek Biosciences, Inc.'s shares (diluted) changed year-over-year?
- Cytek Biosciences, Inc.'s shares (diluted) increased by 2.0% year-over-year, from 126.9M to 129.5M.
- What is the long-term trend for Cytek Biosciences, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s shares (diluted) has grown at a 17.6% compound annual growth rate (CAGR), from 267.1M to 510.6M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Cytek Biosciences, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude